Antiproliferative properties of the lazaroids U-83836E and U-74389G on glioma cells in vitro

Pathology and Oncology Research

Volumn 5, Issue 3, 1999, Pages 223-228

  Durmaz, Ramazan ^a   Deliorman, Selda ^a   Isiksoy, Serap ^a   Uyar, Ruhi ^a   Erol, Kevser ^a   Tel, Esref ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

21 aminosteroids; C6; Glioma; MTT; U 74389G; U 83836E

Indexed keywords

2 [[4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]METHYL] 3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 6 OL; 21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; LAZAROID;

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CYTOTOXICITY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; LIPID PEROXIDATION;

EID: 0032712446     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1053/paor.1999.0202     Document Type: Article

References (32)

1. Alley M C, Scudiero D A, Monks A. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:1988;589-601.
2. Arbit E, Rubinstein A, Di Resta G. The effect of the aminosteroids U-78517G on peritumoral brain oedema. Acta Neurochir (Wien). 51:1990;158-159.
3. Braughler J M, Pregenzer J F. The 21-Aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals. Free Rad Biol Med. 7:1989;125-130.
4. Braughler J M, Hall E D, Jacobson E J. The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs of Future. 14:1989;143-152.
5. Buatti J M, Friedman W A, Theele D P. The lazaroid U-74389G protects normal brain from stereotactic radiosurgery-induced radiation injury. Int J Radiation Oncology Biol Phys. 34:1996;591-597.
6. Carmichael J, De Graff W G, Gazdar A F. Evaluation of tetrazolium-based semiautomated colorimetric assay: assesment of chemosensitivity testing. Cancer Res. 47:1987;936-942.
7. Chen T T, Mealey J. Microculture of human brain tumors. Cancer Chemother Rep. 54:1970;9-14.
8. Donalt Jr. T J, Higgins G M. The effects of high levels of certain steriods on induced lymphocytic leukemia in the rat. Cancer Res. 11:1951;937-942.
9. Durmaz R, Inal M, Angin K. The effects of MK-801 and U-83836E on post-ischemic reperfusion injury in rat brain. Acta Neurobiol Exp. 59:1999;99-104.
10. Franks, L, M, Wilson, P, D, 1977, Origin and ultrasutructure of cells in vitro. International review of cytology. (Eds: Bourne GH, Danielli FJ, Jeon KW),Academic Press, 55, 139.
11. Freshney R I. Effects of glucocorticoids on glioma cells in culture. Minireview on cancer research. Exp Cell Biol. 52:1984;286-292.
12. Giese H, Mertsch K, Blasig I E. Effect of MK-801 and U83836E on a porcine brain capillary endothelial cell barrier during hypoxia. Neuroscience Letters. 191:1995;169-172.
13. Glick R P, Gettleman R, Patel K. Insulin and insulin-like growth factor I in brain tumors: Binding and in vitro effects. Neurosurgery. 24:1989;791-797.
14. Hall E D, Andrus P K, Smith S L. Neuroprotective efficacy of microvasculary-localized versus brain-penetrating antioxidants. Acta Neurochir. 66:1996;107-113.
15. Hall E D, Braughler J M, Yonkers P A. U-78517F: A potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J Pharmacol Exp Ther. 258:1991;688-694.
16. Hall E D, Yonkers P A, Mc Call J M. Effects of the 21-aminosteroid U74006F on experimental head injury in mice. J Neurosurg. 68:1988;456-461.
17. Kim R S, Zaborniak C L, Begleiter A. Antiproliferative properties of aminosteroid antioxidant on cultured cancer cells. Cancer Lett. 64:1992;61-66.
18. King W A, Black K L, Ikezaki K. Novel 21-aminosteroids prevent tumor associated neurological dysfunction. Acta Neurochir (wien). 51:1990;160-162.
19. Kornblith P L. Role of tissue culture in prediction of malignancy. Clin Neurosurg. 25:1978;346-375.
20. Maciunas R J, Mericle R A, Sneed C L. Determination of the lethal dose of dexamethasone for early passage in vitro human glioblastoma cell cultures. Neurosurgery. 33:1993;485-488.
21. Megyesi J F, Farrell C L, Del Maestro R F. Investigation of inhibitor of lipid peroxidation U74006F on tumor growth and protein extravasation in the C6 astrocytoma spheroid implantation glioma model. J Neuro-Oncol. 8:1990;133-137.
22. Mossmann T. Rapid colorimetric assay of cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immun Method. 65:1983;55-63.
23. Motulsky H J, Stannard P, Neubig R. GraphPad Software, Inc, San Diego, 1994-1995. 1995.
24. Müller T B, Haraldseth O, Jones R A. Perfusion and diffusion-weighted MR imaging for in vitro evaluation of treatment with U-74389G in rat stroke model. Stroke. 26:1995;1453-1458.
25. Pertuiset B, Dougherty D, Cromeyer C. Stem cell studies of human malignant brain tumors. Part 2: proliferation kinetics of brain-tumor cells in vitro in early-passage cultures. J Neurosurg. 63:1985;426-432.
26. Russell D S, Rubinstein L J. Pathology of tumours of the nervous system. 1989;Edward Arnold, London. p. 133-140.
27. Smith S L, Scherch H M, Hall E D. Protective effect of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrrage and lipid peroxidative neuronal injury. J Neurosurg. 84:1996;229-233.
28. Thomas D GT, Darling J L, Paul E A. Assay of anticancer drugs tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma. Br J Cancer. 51:1985;525-532.
29. Tsuruo T, Iida H, Tsukagoshi S. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41:1981;1967-1972.
30. Unterman T G, Glick R P, Waites G T. Production of insulin-like growth factor-binding proteins by human central nervous system tumors. Cancer Res. 51:1991;3030-3036.
31. Vincent A JPE, Esandi M C, Avezaat C JJ. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies. Neurosurgery. 41:1997;442-452.
32. Wright R L, Shaumba B, Keller J. The effect of glucocorticosteroids on growth and metabolism of experimental glial tumors. J Neurosurg. 30:1969;140-145.